Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study protocol for a randomised controlled trial

"Background: Either benznidazole (BZN) or nifurtimox (NFX) is recommended as equivalent to treat Trypanosoma cruzi infection. Nonetheless, supportive data from randomised trials is limited to individuals treated with BZN in southern cone countries of Latin America. Methods: The goal of this ran...

Descripción completa

Detalles Bibliográficos
Autores Principales: Villar, Juan Carlos, Herrera, Víctor Mauricio, Pérez Carreño, Juan Guillermo, Váquiro Herrera, Eliana, Castellanos Domínguez, Yeny Zulay, Vásquez, Skarlet Marcell, Cucunubá, Zulma Milena, Prado, Nilda Graciela, Hernández, Yolanda
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: BioMed Central Ltd. 2019
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/23396
https://doi.org/10.1186/s13063-019-3423-3